Brief: Yumanity Therapeutics Achieved A Milestone Which Triggers A $5 Mln Payment Under Research Collaboration With Merck Sharp & Dohme Corp
21/12/2021 13:16
Dec 21 (Reuters) - Yumanity Therapeutics Inc YMTX.O :
* YUMANITY THERAPEUTICS- ACHIEVED A MILESTONE WHICH TRIGGERS
A $5
MILLION PAYMENT UNDER RESEARCH COLLABORATION WITH MERCK SHARP &
DOHME CORP
Further company coverage: YMTX.O
Recent news on Kineta
See all newsBrief: TuHURA Biosciences And Kineta Stockholders Approve Proposed Merger And All Related Proposals
Brief: Kineta Updates KVA12123 Clinical Results From Ongoing Phase 1/2 Vista101 Study At Society For Immunotherapy Of Cancer
U.S. STOCKS ON THE MOVE-Copper miners, Palo Alto Networks, Lowe's
U.S. STOCKS ON THE MOVE-Lineage, J.B. Hunt, McDonald's
Kineta rises on resuming enrollment in early-stage cancer study